Literature DB >> 12377578

Monoamine transporter pharmacology and mutant mice.

Raul R Gainetdinov1, Tatyana D Sotnikova, Marc G Caron.   

Abstract

Monoamine transporters, such as the dopamine transporter, 5-HT transporter and noradrenaline transporter, in the plasma membrane provide effective control over the intensity of monoamine-mediated signaling by recapturing neurotransmitters released by presynaptic neurons. These proteins represent established targets for several psychotropic drugs, including psychostimulants and antidepressants; however, important issues regarding the selectivity and mechanisms of action of these drugs remain unresolved. Although monoamine transporter knockout mice have profound changes in neurotransmission, they provide useful in vivo models to analyze the effects of psychotropic drugs. In this review, we summarize recent insights into the pharmacology of psychotropic drugs using mice in which the genes encoding these transporters have been deleted.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12377578     DOI: 10.1016/s0165-6147(02)02044-8

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  33 in total

Review 1.  Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6.

Authors:  Nian-Hang Chen; Maarten E A Reith; Michael W Quick
Journal:  Pflugers Arch       Date:  2003-04-29       Impact factor: 3.657

2.  Role of serotonin in cocaine effects in mice with reduced dopamine transporter function.

Authors:  Yolanda Mateo; Evgeny A Budygin; Carrie E John; Sara R Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-22       Impact factor: 11.205

3.  Coordination and modulation of locomotion pattern generators in Drosophila larvae: effects of altered biogenic amine levels by the tyramine beta hydroxlyase mutation.

Authors:  Lyle E Fox; David R Soll; Chun-Fang Wu
Journal:  J Neurosci       Date:  2006-02-01       Impact factor: 6.167

Review 4.  Dopamine signaling architecture in Caenorhabditis elegans.

Authors:  Paul W McDonald; Tammy Jessen; Julie R Field; Randy D Blakely
Journal:  Cell Mol Neurobiol       Date:  2006-05-25       Impact factor: 5.046

5.  Deletion of Go2alpha abolishes cocaine-induced behavioral sensitization by disturbing the striatal dopamine system.

Authors:  Irene Brunk; Christian Blex; Carles Sanchis-Segura; Jan Sternberg; Stephanie Perreau-Lenz; Ainhoa Bilbao; Heide Hörtnagl; Jens Baron; Judyta Juranek; Gregor Laube; Lutz Birnbaumer; Rainer Spanagel; Gudrun Ahnert-Hilger
Journal:  FASEB J       Date:  2008-07-07       Impact factor: 5.191

6.  Characterization of conditioned place preference to cocaine in congenic dopamine transporter knockout female mice.

Authors:  Ivan O Medvedev; Raul R Gainetdinov; Tatyana D Sotnikova; Laura M Bohn; Marc G Caron; Linda A Dykstra
Journal:  Psychopharmacology (Berl)       Date:  2005-02-18       Impact factor: 4.530

7.  Norepinephrine transporter inhibitors and their therapeutic potential.

Authors:  Jia Zhou
Journal:  Drugs Future       Date:  2004-12       Impact factor: 0.148

8.  Interaction of catechol and non-catechol substrates with externally or internally facing dopamine transporters.

Authors:  Ying-Jian Liang; Juan Zhen; Nianhang Chen; Maarten E A Reith
Journal:  J Neurochem       Date:  2009-03-11       Impact factor: 5.372

Review 9.  Trends in the development of new antidepressants. Is there a light at the end of the tunnel?

Authors:  Pal Pacher; Valeria Kecskemeti
Journal:  Curr Med Chem       Date:  2004-04       Impact factor: 4.530

10.  Mechanism for cocaine blocking the transport of dopamine: insights from molecular modeling and dynamics simulations.

Authors:  Xiaoqin Huang; Howard H Gu; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2009-11-12       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.